Monitoring immune-checkpoint blockade: response evaluation and biomarker development
Dana-Farber Cancer Institute · Brigham and Women's Hospital · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,083
total citations
- FWCI
- 41.30
- Percentile
- 100%
- References
- 89
Citations per year
Authors
4- MNMizuki NishinoCorresponding
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Dana-Farber Brigham Cancer Center
- NHNikhil H. Ramaiya
Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
- HHHiroto Hatabu
Dana-Farber Brigham Cancer Center, Brigham and Women's Hospital, Dana-Farber Cancer Institute
- FSF. Stephen Hodi
Dana-Farber Cancer Institute
Topics & keywords
Topics
Keywords
- Immunotherapy
- Medicine
- Immune checkpoint
- Blockade
- Biomarker
- Cancer immunotherapy
- Immune system
- Biomarker discovery
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.